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Objective: To describe infant mortality trends and associated factors
among infants born to mothers enrolled in a prevention of mother-to-child
transmission (PMTCT) program.
Study Design: A nested case–control study of human
immunodeﬁciency virus (HIV)-positive and -negative pregnant women
enrolled from the national PMTCT program at 36 weeks of gestation
attending three peri-urban clinics in Zimbabwe offering maternal and
child health care. Mother–infant pairs were followed up from delivery,
and at 6 weeks, 4 months and 9 months.
Results: A total of 1045 mother and singleton infant pairs, 474 HIV-
positive and 571 HIV-negative mothers, delivered 469 and 569 live infants,
respectively. Differences in mortality were at 6 weeks and 4 months, RR
(95% CI) 9.71 (1.22 to 77.32) and 21.84 (2.93 to 162.98), respectively.
Overall, 9-month mortality rates were 150 and 47 per 1000 person-years
for infants born to HIV-positive and HIV-negative mothers, respectively.
Proportional hazard ratio of mortality for children born to HIV-positive
mothers was 3.21 (1.91 to 5.38) when compared with that for children
born to HIV-negative mothers.
Conclusion: Maternal HIV exposure was associated with higher
mortality in the ﬁrst 4 months of life. Infant’s HIV status was the strongest
predictor of infant mortality. There is a need to screen infants for HIV
from delivery and throughout breastfeeding.
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Introduction
Prevention of mother-to-child transmission (PMTCT) of
human immunodeﬁciency virus (HIV) has become one of the
essential elements of the control strategies for the African HIV
pandemic.
1–3
HIV infection has been noted to affect child mortality directly by
mother-to-child transmission (MTCT) and indirectly by maternal
HIV status, as a mother’s death has a negative impact on the
child’s health.
4 The epidemic among children mirrors that among
women of childbearing age.
5 Child mortality is a possible outcome
for PMTCT interventions, as cases of pediatric HIV infection averted
should also translate into deaths averted. However, the results of
some trials suggest otherwise, especially in the ﬁrst 2 years of
life.
5–7
To observe a meaningful difference in child mortality, some
authors suggest a prolonged follow-up of up to 5 years, whereas
others feel that it is important to establish age-speciﬁc child
mortality.
1,8 Children born to HIV-infected mothers are estimated to
be thrice more likely to die than those born to HIV-negative
mothers and this has been observed to continue throughout the
childhood years.
9–12In Zimbabwe, infant mortality has been found
to be 17% among infants born to HIV-infected mothers and 2%
among seronegative mothers before any PMTCT interventions.
3,12,13
In this paper, we describe age-speciﬁc mortality trends of
children born to HIV-positive and -negative mothers delivered
under a PMTCT program. The aim is to ﬁnd the extent to
which PMTCT intervention has inﬂuenced child mortality
in this Zimbabwean cohort. We also describe and compare the risk
factors for infant mortality by maternal HIV status in this
population.
Methods
Design of the study: A nested case–control study enrolled pregnant
women from the national PMTCT program.
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www.nature.com/jpStudy sites: Three peri-urban clinics around Harare (Epworth;
St Mary’s and Seke North) offering maternal and child health
services participated in the study.
Study population: Infants born to mothers booked at the
respective Antenatal Clinics, having gone through voluntary
counseling and testing under the national PMTCT program, were
followed up together with their mothers from delivery up to
9 months after birth.
Inclusion criteria: Women from the national PMTCT program
who were 36-week pregnant and had received pre- and post-HIV
counseling were included if they intended to deliver their index
infants at one of the three participating study sites. Multiple births
were excluded.
Baseline assessments: A questionnaire sourcing
sociodemographic, reproductive history, contraception and
knowledge of STI/HIV signs and symptoms, as well as feeding
practices was interview-administered to the mothers.
Intervention: HIV-positive mothers received a single 200mg
nevirapine dose at the onset of labor, and their infants received a
single 1 to 2mg nevirapine dose within 72h of delivery. Follow-up
of the infants started at delivery with a physical examination
including anthropometrical measurements.
Cord blood was collected from the infant at birth and thereafter
venous blood was collected at each follow-up visit; 6 weeks, 4 months
and 9 months for HIV-DNA PCR test using cell pellets by prototype
Roche Amplicor version 1.5 qualitative PCR assay (Roche Diagnostic
Systems, Branchburg, New Jersey, USA). Infant feeding practices
were also assessed at each time point. Infants were classiﬁed
at birth according to maternal HIV status that was determined
at approximately 36 weeks of gestation and this status was
maintained for this analysis throughout the ‘9 months’ of follow-up.
At each scheduled visit, information was sourced from the
mother about the health status of the infant. For this analysis, the
mother and infant were considered alive if they showed up for their
visit or in cases of migration home visits were conducted and their
relatives conﬁrmed that they were alive during the period under
observation. They were considered dead through evidence from
verbal autopsy for the infant given by either the mother or
caregiver and for the mother by the next of kin. Where available
and possible, clinical records were also assessed to ascertain the
cause of death. The potential child mortality risk factors included
were birth weight, breastfeeding, infant’s HIV serostatus, mother’s
age, marital status and maternal HIV status.
Age-speciﬁc mortality was assessed at delivery, and at 6 weeks,
4 months and 9 months.
Ethical considerations: Both the Medical Research Council of
Zimbabwe and the Ethical Review Committee in Norway approved
the study.
Mothers who agreed to participate in the study gave informed
written consent for themselves and their index infants to be
followed up from delivery.
Statistical analysis
Data were entered and analyzed using SPSS and STATA Version 9
from StataCorp, College Station, TX, USA. Infants’ anthropometrical
characteristics at delivery were described according to the maternal
HIV status and a description of the maternal baseline characteristics
was given.
A table showing deceased infants and the proportions dying by
maternal HIV status at each scheduled stipulated study visit is
presented. Calculations were carried out to show the deaths,
percentage of deceased infants by covariates, relative risks with
their 95% conﬁdence interval for the covariates and stratiﬁed by
HIV status. Stepwise regression was used to construct models
showing the most signiﬁcant covariates for 9-month child
mortality. Survival analysis was used to calculate 9-month
mortality rates, proportional hazard ratio for death due to HIV, as
well as log-rank tests for equality of survival analysis. We further
analyzed the effect of infant feeding options on mortality, that is,
mixed feeding, exclusive breastfeeding and not having been
breastfed at all. Statistical calculations were carried out only on
singleton and live born infants.
Results
A total of 479 HIV-positive and 571 HIV-negative pregnant women
were included in the study and they delivered 484 (ﬁve of which
were multiple births) and 571 infants, respectively. After exclusion
of 5 multiple births and 7 stillbirths, 469 HIV-positive and 569 HIV-
negative mother–infant pairs were included in this analysis.
Characteristics of the mothers
HIV-positive mothers were older than the HIV-negative mothers,
mean (s.d.) age in years 26.1 (4.9) and 23.5 (5.0) P<0.001. They
also reported more pregnancies and had more children, mean
(s.d.) pregnancy 2.5 (1.2) and parity of 1.6 (1.2) compared with
2.0 (1.1) and parity of 0.9 (1.1) for the HIV-negative mothers,
respectively, P<0.001.
Infants’ characteristics
Anthropometrical measurements of the infants at birth were
signiﬁcantly different in terms of mean weight and length between
those born of HIV-positive and those of HIV-negative mothers (Table 1).
Mortality
Over the 9 months of follow-up, a total of 51 (10.9%) infants of
HIV-positive mothers died compared with 20 (3.5%) born to
HIV-negative mothers, P<0.001. Mortality rates of 9 months were
150 per 1000 person-years among infants born to HIV-positive and
47 per 1000 person-years among those born to HIV-negative
mothers. Proportional hazard ratio for mortality over the 9-month
period for children born to HIV-positive mothers was 3.21 (1.91 to
5.38) when compared with that for children born to HIV-negative
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children born to HIV-positive mothers was signiﬁcantly different
from that for children born to HIV-negative mothers, P< 0.001.
Signiﬁcant differences in child mortality by HIV status were
observed at 6 weeks and 4 months, whereas at 9 months the
differences in mortality had disappeared (see Table 2).
Among the 91 infants who tested HIV-positive over the 9-month
period, 24.2% of them died compared with 5.2% of those who did
not seroconvert, relative risk 4.67 (2.97 to 7.36), P<0.001.
Infant- and maternal-related risk factors
In univariate analysis among infants born to HIV-positive mothers,
infant HIV positivity, having a deceased mother and low birth
weight were signiﬁcant risk factors for 9-month infant mortality.
Infants not breastfed at all had the highest risk of dying compared
with those exclusively breastfed or had mixed feeding regardless of
the mother’s HIV status (Table 3).
Among infants born to HIV-negative mothers, having a deceased
mother was the only risk factor for mortality (see Table 4).
After the stepwise multivariate analysis among infants born to
HIV-positive mothers, it is the infant’s HIV infection that remained as
the only signiﬁcant risk factor for mortality at 9 months, incidence
risk rate 5.30 (2.15 to 13.05). Among infants born to HIV-negative
mothers, having a deceased mother remained a signiﬁcant risk
factor, incidence risk rate 40.41 (19.36 to 84.38), P¼0.001.
Discussion
Maternal HIV-positive status signiﬁcantly predisposes the infants to
higher mortality, especially in the ﬁrst 4 months of life. Consistent
Table 1 Anthropometrical status of the infants at delivery by maternal HIV status
Infant factors Infants of HIV-positive mothers Infants of HIV-negative mothers P-value
Weight (mg) at delivery N¼425 N¼478
Mean (s.d.) 3013 (453) 3078 (414) 0.025
Length (cm) of infant N¼367 N¼409
Mean (s.d.) 48 (4) 49 (3) 0.031
Head circumference (cm) N¼364 N¼410
Mean (s.d.) 34 (3) 34 (2) 0.782
Table 2 Deceased infants and proportions dying by maternal HIV status and study visit
Time of visit HIV-positive mothers,N¼469 HIV-negative mothers,N¼569 Relative risk (95% CI) P-value
Infants deceased at 6 weeks 8 (1.7%) 1 (0.2%) 9.71 (1.22–77.32) 0.008
Infants deceased at 4 months 18 (3.8%) 1 (0.2%) 21.84 (2.93–162.98) <0.001
Infants deceased at 9 months 25 (5.3%) 18 (3.2%) 1.69 (0.93–3.05) 0.081
Overall mortality 51 (10.9%) 20 (3.5%) 3.09 (1.87–5.11) <0.001
Table 3 Infant feeding options as a risk factor for infant mortality by maternal HIV status
Feeding option and time Deceased infants of
HIV-positive mothers
Odds ratio
(95% CI)
Deceased infants of
HIV-negative mothers
Odds ratio
(95% CI)
6 weeks
Exclusive, n (%) 23 (9.1) Referent 4 (1.9) Referent
Mixed, n (%) 9 (12.0) 1.3 (0.6–2.9) 6 (3.9) 2.1 (0.6–7.3)
Not breastfed at all, n (%) 3 (10.7) 1.2 (0.4–3.9) 2 (15.4) 8.1 (1.5–44.3)
4 months
Exclusive, n (%) 6 (4.9) Referent 1 (3.0) Referent
Mixed, n (%) 6 (4.5) 0.9 (0.3–2.9) 7 (3.6) 1.2 (0.2–9.6)
Not breastfed at all, n (%) 5 (12.8) 2.6 (0.8–8.6) 1 (16.7) 5.5 (0.3–87.9)
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Journal of Perinatologywith the previous studies even before PMTCT, maternal HIV
exposure increased the risk of infant mortality. This risk is
regardless of the fact that the infant would have escaped the
infection itself.
1–4 The excess risk for mortality in our study is
slightly higher than that reported by Zaba
10 in the cohort of three
countries.
There is need for further research with regards to maternal HIV
status and intrauterine, intrapartum deaths. High infant mortality
was observed among infants who tested DNA PCR-positive at birth,
with about 24% of them dying in the ﬁrst 9 months of life. This
emphasizes the shortcomings of the single-dose antiretroviral
prophylaxis, thus supporting what previous studies have
observed that the majority of the deceased infants were infected
in utero.
9,12
Signiﬁcant differences were observed at the 6-week visit among
infants of HIV-positive mothers as compared with those born to
HIV-negative mothers. This difference in mortality reached a peak
at 4 months where infants born of HIV-positive mothers were
almost 22 times more likely to die. The peak period of this
mortality is when solid foods or animal milk is introduced to the
infants. Mixed feeding predisposes the infant to scarring and sores
in the intestines, thereby facilitating the entry of the HIV virus.
It also predisposes the infants to risk of diarrheal and respiratory
infections.
13 At 9 months, there was no difference in mortality
among infants born to HIV-negative and HIV-positive mothers. This
is in agreement with other reports observing that child mortality
decreases with age.
4–8,11,12 Although few studies have reported on
period infant mortality, the mortality trend in our study indicates
that those infants who survive the ﬁrst 4 months of life have a
higher chance of survival irrespective of the mother’s HIV
serostatus.
9,10 Overall about 8% of the infants had a low birth
weight and around 14% of them died within the ﬁrst 9 months of
life. Although not statistically signiﬁcant, infants not breastfed at
all were more likely to die regardless of maternal HIV status. This is
mostly attributed to the fact that these infants will succumb to
other infections such as diarrhea or malnutrition itself.
3 On the
other hand, low birth weight infants, if not breastfed, are more
likely to die especially in low-income countries, as has been
reported in other studies.
9 This can also be attributed to the
counseling and support on feeding options, which is more focused
and targeted toward the HIV-positive mothers. HIV-negative
mothers who decided not to breastfeed, doubting their status, could
have considered themselves at risk, but unfortunately they did not
get the kind of support given to their counterparts. Feeding options
Table 4 Proportion of infant deaths by covariates stratiﬁed by maternal HIV status
Risk factor Deceased infants of
HIV-positive mothers,N¼50
Relative risk
(95% CI)
Deceased infants of
HIV-negative mothers,N¼23
Relative risk
(95% CI)
Birth weight
<2500g 8/47 (17.0%) 2.15 (1.09–4.26) 1/16 (6.3%) 0.92 (0.13–6.75)
Maternal anemia
<10g per 100ml 6/32 (18.8%) 1.28 (0.56–2.93) 0/20 (0%) 0 (incalculable)
Maternal mortality
Deceased 7/51 (13.7%) 6.06 (3.48–10.55) 2/20 (10.0%) 20.96 (8.35–52.62)
Ever breastfed over 9 months
Not at all 5/38 (13.2%) 1.19 (0.49–2.88) 2/14 (14.3%) 3.46 (0.83–14.42)
Sex of infant
Male 27/44 (61.4%) 1.49 (0.84–2.64) 5/13 (38.5%) 0.71 (0.24–2.14)
Maternal history of infant death
Yes 10/50 (20.0%) 1.34 (0.70–2.56) 3/20 (15.0%) 2.77 (0.85–8.98)
Maternal history of stillbirth
Yes 4/51 (7.8%) 0.93 (0.35–2.44) 3/20 (15.0%) 2.75 (0.85–8.91)
Infant’s HIV status
HIV-positive 22/51 (43.1%) 3.15 (1.90–5.22) NA NA
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Journal of Perinatologyand HIV remain a controversial issue with different outcomes
according to different settings.
3 However, in this study where over
85% of the infants were breastfed regardless of the mother’s HIV
status, the small number of infants who were not breastfed at all
could have affected our observation.
Low birth weight was the only infant-related risk factor that was
signiﬁcantly associated with higher mortality for infants born to
HIV-positive mothers. It was, however, confounded by other factors
in the multivariate model. Maternal death was a strong predictor of
infant mortality regardless of the mother’s HIV status. This is
consistent with reported studies whereby maternal health directly
affects the infant’s health.
4 Risk factors for infant mortality were
more pronounced among infants born to HIV-positive mothers
than for the HIV-negative mothers. The HIV status of the infant
itself came out as the strongest predictor of whether the child
would survive or not, even after controlling for other factors. The
importance of screening all HIV-exposed infants at delivery and
throughout the breastfeeding period cannot be over emphasized.
There should be close clinical monitoring for the HIV-seropositive
infants, for CD4 counts, viral loads and commencing them on ARV
drugs as and when appropriate.
This study was conducted at the time when PMTCT initiatives
were being introduced in the country. This information on infant
mortality while PMTCT was in its infancy will provide some insight
into the impact of PMTCT on child mortality. Most of the infants in
our study died from respiratory tract infections and diarrheal
diseases, but we did not go further into assessing the actual
morbidity leading to a particular death for this paper. This restricts
the extent to which we can generalize this observation.
12 However,
we have managed to highlight the age-speciﬁc effect of maternal
HIV exposure and the risk factors for infant mortality in the
PMTCT era.
Risk factors associated with higher infant mortality were
maternal mortality and for infant-related factors it was infant’s HIV
status and low birth weight, the former being the strongest
predictor of infant survival. Infant mortality remains high in this
HIV-prevalent population and more effort has to be put in
establishing the actual cause of this high mortality even within
PMTCT initiatives.
We conclude that maternal HIV exposure is associated with
higher mortality in the ﬁrst 4 months of life. Prevention of HIV
among women remains a priority. There is need to strengthen
current PMTCT programs, by screening pregnant women early for
HIV and giving more efﬁcacious drug regimens to HIV-positive
mothers guided by their CD4 and viral load counts. Interventions to
reduce both HIV transmission and infant mortality should be
targeted in the ﬁrst 4 months of life. All infants born to HIV-positive
mothers should be screened for HIV at delivery and throughout
the breastfeeding period, and ARV therapy should be initiated
as and when necessary, offering continued clinical care and
support.
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